These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22496261)

  • 21. Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough?
    Singh M; Chin SH; Giles PD; Crothers D; Al-Allaf K; Khan JM
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):556-61. PubMed ID: 20305563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inconsistent Guideline Recommendations for Cardiovascular Prevention and the Debate About Zeroing in on and Zeroing LDL-C Levels With PCSK9 Inhibitors.
    Ioannidis JPA
    JAMA; 2017 Aug; 318(5):419-420. PubMed ID: 28738115
    [No Abstract]   [Full Text] [Related]  

  • 23. The safety of statins in children.
    Lamaida N; Capuano E; Pinto L; Capuano E; Capuano R; Capuano V
    Acta Paediatr; 2013 Sep; 102(9):857-62. PubMed ID: 23631461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry.
    Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS
    J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
    Kerst LL; Mauro VF
    Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Stone NJ; Robinson JG; Lichtenstein AH; Bairey Merz CN; Blum CB; Eckel RH; Goldberg AC; Gordon D; Levy D; Lloyd-Jones DM; McBride P; Schwartz JS; Shero ST; Smith SC; Watson K; Wilson PW;
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt B):2889-934. PubMed ID: 24239923
    [No Abstract]   [Full Text] [Related]  

  • 27. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 28. Statins and the soul of medicine.
    Ornish D
    Am J Cardiol; 2002 Jun; 89(11):1286-90. PubMed ID: 12031729
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of low-density lipoprotein cholesterol in assessment and management of cardiovascular disease risk.
    Jialal I; Remaley AT
    Clin Pharmacol Ther; 2014 Jul; 96(1):20-2. PubMed ID: 24942398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins and almonds to lower lipoproteins (the STALL Study).
    Ruisinger JF; Gibson CA; Backes JM; Smith BK; Sullivan DK; Moriarty PM; Kris-Etherton P
    J Clin Lipidol; 2015; 9(1):58-64. PubMed ID: 25670361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-thrombotic effects of statins.
    Kearney D; Fitzgerald D
    J Am Coll Cardiol; 1999 Apr; 33(5):1305-7. PubMed ID: 10193731
    [No Abstract]   [Full Text] [Related]  

  • 32. [HDL and CETP in atherogenesis].
    Pöss J; Böhm M; Laufs U
    Dtsch Med Wochenschr; 2010 Feb; 135(5):188-92. PubMed ID: 20082258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overview of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.
    Robinson JG
    Future Cardiol; 2014 Mar; 10(2):149-52. PubMed ID: 24762237
    [No Abstract]   [Full Text] [Related]  

  • 34. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 35. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of disease: HDL metabolism as a target for novel therapies.
    Rader DJ
    Nat Clin Pract Cardiovasc Med; 2007 Feb; 4(2):102-9. PubMed ID: 17245404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins.
    Kertland H
    J Obstet Gynaecol Can; 2003 Mar; 25(3):231-4. PubMed ID: 12610676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent National Cholesterol Education Program Adult Treatment Panel III update: adjustments and options.
    Stone NJ; Bilek S; Rosenbaum S
    Am J Cardiol; 2005 Aug; 96(4A):53E-59E. PubMed ID: 16098845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The case for medical treatment in chronic stable coronary artery disease.
    Nash DT
    Arch Intern Med; 2005 Dec 12-26; 165(22):2587-9, discussion 2593-4. PubMed ID: 16344414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.